These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Outcome of Dupuytren Contractures After Collagenase Clostridium Histolyticum Injection: A Single-institution Experience. Hwee YK; Park D; Vinas M; Litts C; Friedman D Ann Plast Surg; 2017 Aug; 79(2):145-148. PubMed ID: 28604542 [TBL] [Abstract][Full Text] [Related]
28. Dupuytren's Contracture. The Safety and Efficacy of Collagenase Treatment. Odinsson A; Brenne LE; Lurie TB; Finsen V J Hand Surg Asian Pac Vol; 2016 Jun; 21(2):187-92. PubMed ID: 27454632 [TBL] [Abstract][Full Text] [Related]
29. Adverse effects associated with collagenase clostridium histolyticum in Dupuytren disease: A prospective study. Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P Orthop Traumatol Surg Res; 2018 Oct; 104(6):901-905. PubMed ID: 30253866 [TBL] [Abstract][Full Text] [Related]
30. [Treatment of Dupuytren's contracture by means of injectable collagenase: first clinical experiences]. Spanholtz TA; Holzbach T; Wallmichrath J; Pototschnig A; Deglmann C; Frick A; Giunta RE Handchir Mikrochir Plast Chir; 2011 Oct; 43(5):275-80. PubMed ID: 21935844 [TBL] [Abstract][Full Text] [Related]
31. Dynamism in Dupuytren's contractures. Rodrigues JN; Zhang W; Scammell BE; Davis TR J Hand Surg Eur Vol; 2015 Feb; 40(2):166-70. PubMed ID: 24664160 [TBL] [Abstract][Full Text] [Related]
32. The level of anti-topoisomerase I antibodies highly correlates with metacarpophalangeal and proximal interphalangeal joints flexion contractures in patients with systemic sclerosis. Radić M; Martinović Kaliterna D; Ljutić D Clin Exp Rheumatol; 2006; 24(4):407-12. PubMed ID: 16956431 [TBL] [Abstract][Full Text] [Related]
33. Comparison of Treatment Outcome After Collagenase and Needle Fasciotomy for Dupuytren Contracture: A Randomized, Single-Blinded, Clinical Trial With a 1-Year Follow-Up. Strömberg J; Ibsen-Sörensen A; Fridén J J Hand Surg Am; 2016 Sep; 41(9):873-80. PubMed ID: 27473921 [TBL] [Abstract][Full Text] [Related]
34. Tissue adaptation rate in the treatment of Dupuytren contracture. Giesberts RB; Ter Haar AM; Sanderman GM; Hekman EEG; Verkerke GJ J Hand Ther; 2020; 33(1):80-86. PubMed ID: 30926179 [TBL] [Abstract][Full Text] [Related]
35. Advances in the management of Dupuytren disease: collagenase. Hentz VR; Watt AJ; Desai SS; Curtin C Hand Clin; 2012 Nov; 28(4):551-63. PubMed ID: 23101605 [TBL] [Abstract][Full Text] [Related]
36. One-year results of needle fasciotomy and collagenase injection in treatment of Dupuytren's contracture: A two-centre prospective randomized clinical trial. Scherman P; Jenmalm P; Dahlin LB J Hand Surg Eur Vol; 2016 Jul; 41(6):577-82. PubMed ID: 26631343 [TBL] [Abstract][Full Text] [Related]
37. Results of surgical treatment of Dupuytren's disease in women: a review of 109 consecutive patients. Anwar MU; Al Ghazal SK; Boome RS J Hand Surg Am; 2007 Nov; 32(9):1423-8. PubMed ID: 17996779 [TBL] [Abstract][Full Text] [Related]
39. A new finger-preserving procedure as an alternative to amputation in recurrent severe Dupuytren contracture of the small finger. Eiriksdottir A; Atroshi I BMC Musculoskelet Disord; 2019 Jul; 20(1):323. PubMed ID: 31288790 [TBL] [Abstract][Full Text] [Related]
40. New insights into the immediate outcome of collagenase injections for Dupuytren's contracture. Warwick DJ; Graham D; Worsley P J Hand Surg Eur Vol; 2016 Jul; 41(6):583-8. PubMed ID: 26307140 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]